Abstract
Various topical and systemic treatments have shown efficacy in plaque and palmoplantar psoriasis; however, studies regarding efficacy in inverse psoriasis are few. The authors present a case of a patient with severe inverse psoriasis who was successfully treated with efalizumab, resulting in complete and sustained remission during prolonged maintenance therapy.
MeSH terms
-
Aged
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents / administration & dosage
-
Dermatologic Agents / therapeutic use*
-
Humans
-
Injections, Subcutaneous
-
Male
-
Psoriasis / drug therapy*
-
Remission Induction
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
efalizumab